Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Radio-Labeled huA33 Antibody in Colorectal Cancer
This study is currently recruiting participants.
Study NCT00199862 Information provided by Ludwig Institute for Cancer Research
First Received: September 13, 2005 Last Updated: March 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Neoplasms
Colorectal Cancer
Colorectal Tumor
Colorectal Carcinoma
Additional conditions recognized in this trial
Carcinoma
Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Rectal Diseases
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Iodine
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Local
Growth Substances
Immunologic Factors
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Trace Elements
Sponsors listed in this trial
Ludwig Institute for Cancer Research
Memorial Sloan-Kettering Cancer Center
Back to top of Main Content
